Drug-related psoriasis.
作者信息
Ganeva Maria, Gancheva Tanya, Deliyska Radostina, Gancheva Desislava, Hristakieva Evgenya
机构信息
Section of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria.
Clinic of Dermatology and Venereology, UMHAT "Prof. Dr. Stoyan Kirkovich" AD, Stara Zagora, Bulgaria.
出版信息
Postepy Dermatol Alergol. 2023 Jun;40(3):470-471. doi: 10.5114/ada.2022.124418. Epub 2023 Jan 25.
Abstract
摘要
相似文献
1
Drug-related psoriasis.药物相关性银屑病
Postepy Dermatol Alergol. 2023 Jun;40(3):470-471. doi: 10.5114/ada.2022.124418. Epub 2023 Jan 25.
2
Drug-induced psoriasis: clinical perspectives.药物性银屑病：临床视角
Psoriasis (Auckl). 2017 Dec 7;7:87-94. doi: 10.2147/PTT.S126727. eCollection 2017.
3
[Drug-related psoriasis].
Rev Med Liege. 2012 Mar;67(3):139-42.
4
Acute generalized exanthematous pustulosis and psoriasis: what can be learned from comorbidities.急性泛发性发疹性脓疱病和银屑病：从合并症中可以学到什么。
G Ital Dermatol Venereol. 2019 Aug;154(4):413-417. doi: 10.23736/S0392-0488.19.06157-1. Epub 2019 Feb 14.
5
Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis.银屑病患者长期日常实践队列中依那西普药物生存的决定因素。
Br J Dermatol. 2014 Feb;170(2):415-24. doi: 10.1111/bjd.12648.
6
Cytokinetics and chemotherapy of psoriasis.银屑病的细胞动力学与化疗
J Invest Dermatol. 1976 Jul;67(1):26-30. doi: 10.1111/1523-1747.ep12512476.
7
Clinical monograph for drug formulary review: systemic agents for psoriasis/psoriatic arthritis.药物处方集评审临床专论：银屑病/银屑病关节炎的全身用药
J Manag Care Pharm. 2005 Jan-Feb;11(1):33-55. doi: 10.18553/jmcp.2005.11.1.33.
8
Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization.魁北克地区使用阿普司特治疗中重度斑块状银屑病的真实世界经验：基于药物利用和医疗资源利用的分析。
J Cutan Med Surg. 2020 Nov/Dec;24(6):573-587. doi: 10.1177/1203475420936652. Epub 2020 Jun 29.
9
Drug discontinuation in pregnant women with psoriasis: The PSO-MOTHER cohort study.孕妇银屑病的药物停用：PSO-MOTHER 队列研究。
Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):904-912. doi: 10.1002/pds.5030. Epub 2020 Jun 5.
10
Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications.用于治疗银屑病的生物制品：治疗靶点、药效学及疾病-药物-药物相互作用的影响
AAPS J. 2014 Sep;16(5):938-47. doi: 10.1208/s12248-014-9637-0. Epub 2014 Jul 4.
本文引用的文献
1
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.银屑病的流行病学和合并症：一篇叙述性综述。
Front Immunol. 2022 Jun 10;13:880201. doi: 10.3389/fimmu.2022.880201. eCollection 2022.
2
Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021.2016年至2021年美国食品药品监督管理局不良事件报告系统中报告的白癜风不良事件及相关药物。
J Am Acad Dermatol. 2023 Jan;88(1):197-199. doi: 10.1016/j.jaad.2022.04.010. Epub 2022 Apr 12.
3
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review.系统糖皮质激素使用与银屑病关节炎和银屑病发作的关系：系统评价。
Rheumatology (Oxford). 2022 Nov 2;61(11):4232-4244. doi: 10.1093/rheumatology/keac129.
4
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence.血管紧张素转换酶抑制剂的使用与银屑病发病风险的系统评价和荟萃分析。
Sci Rep. 2021 May 11;11(1):10037. doi: 10.1038/s41598-021-89490-z.
5
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis.银屑病患者在有银屑病病史的情况下接受全身糖皮质激素治疗后出现病情发作。
JAMA Dermatol. 2021 Feb 1;157(2):198-201. doi: 10.1001/jamadermatol.2020.4219.
6
The role of xenobiotics in triggering psoriasis.外源性物质在引发银屑病中的作用。
Arch Toxicol. 2020 Dec;94(12):3959-3982. doi: 10.1007/s00204-020-02870-8. Epub 2020 Aug 24.
7
Systemic corticosteroid use in psoriasis: a national survey of board-certified dermatologists.银屑病中全身使用皮质类固醇：对皮肤科专科医生的全国性调查。
J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e116-e117. doi: 10.1111/jdv.15291. Epub 2018 Nov 13.
8
Drug-induced psoriasis: clinical perspectives.药物性银屑病：临床视角
Psoriasis (Auckl). 2017 Dec 7;7:87-94. doi: 10.2147/PTT.S126727. eCollection 2017.
9
Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?系统皮质类固醇治疗银屑病：哪些是事实，哪些是虚构？
J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1022-5. doi: 10.1111/j.1468-3083.2012.04656.x. Epub 2012 Jul 25.
10
Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score.药物性银屑病：基于证据的概述及银屑病药物性皮疹概率评分的介绍
Cutan Ocul Toxicol. 2006;25(1):1-11. doi: 10.1080/15569520500536568.
Zotero 插件